Cell-killing molecules and methods of use thereof

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 48/00 (2006.01) A61K 31/7088 (2006.01) A61K 38/17 (2006.01) A61K 38/46 (2006.01) A61K 39/395 (2006.01) A61K 47/48 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2514841

The invention provides compositions comprising amino acid sequences that have cell killing activity, nucleic acid sequences encoding them, antibodies that specifically bind with them, and methods of using these compositions for increasing and/or reducing cell death, detecting cell death, diagnosing diseases associated with altered cell death, and methods for identifying test agents that alter cell death.

L'invention concerne des compositions qui comprennent des séquences d'acides aminés présentant une activité d'élimination de cellules, des séquences d'acides nucléiques les codant, des anticorps se liant de manière spécifique à celles-ci; ainsi que des méthodes d'utilisation desdites compositions destinées à augmenter et/ou à réduire la mort cellulaire, à détecter la mort cellulaire, à diagnostiquer des maladies associées à la mort cellulaire altérée, et des méthodes d'identification d'agents de test qui altèrent la mort cellulaire.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Cell-killing molecules and methods of use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cell-killing molecules and methods of use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cell-killing molecules and methods of use thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1832206

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.